Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6400
-0.0300 (-4.48%)
At close: Mar 17, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 41.43 million as of March 18, 2026. Its market cap has increased by 7.30% in one year.
Market Cap
41.43M
Enterprise Value
24.24M
Revenue
19.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 41.43M, a decrease of -82.41%. That is a compound annual growth rate of -32.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 41.43M | -6.46% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QBNK Holding AB | 63.38M |
| BiBBInstruments AB | 55.61M |
| Redsense Medical AB | 54.27M |
| Sound Dimension AB | 52.99M |
| Touchtech AB | 46.78M |
| Vidhance AB | 35.90M |
| Biofrigas Sweden AB | 34.74M |
| Lightning Group AB | 28.63M |